Indolylalkylidenehydrazine-carboximidamide derivatives as 5-hydroxytryptamine-6 ligands
申请人:Wyeth
公开号:US20040002527A1
公开(公告)日:2004-01-01
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of a disorder relating to or affected by the 5-HT6 receptor.
1
本发明提供了一种I式化合物以及其在治疗与或受5-HT6受体影响的疾病中的应用。
FROHN, H. I.;PAHLMANN, W., J. FLOUR. CHEM., 1984, 24, N 2, 219-232